RESUMEN
OBJECTIVE: To verify corneal alterations in patients with keratoconus who wear scleral contact lenses (ScCLs), focusing on corneal endothelial assessment. METHODS: Scleral contact lenses were fitted in 22 patients with keratoconus. During a 90-day follow-up, patients were assessed in three visits: at baseline, after 30 days, and after 90 days. Patients underwent visual acuity measurement, slitlamp biomicroscopy of the anterior segment, specular microscopy of the corneal endothelium, corneal pachymetry, measurement of the clearance between the cornea and the lens, and follow-up of ectasia. RESULTS: Variables related to endothelial morphology and pachymetry values did not change significantly over time. Central clearance measurements decreased in the 90-day period. No progression of corneal ectasia was observed, neither were infectious or inflammatory processes in the same period. CONCLUSION: Daily wear of ScCLs in patients with keratoconus was not associated with adverse effects on the cornea or endothelium over a period of 90 days nor was there evidence of disease progression. Central clearance values diminished over that period, but the significance of this observation remains unclear.
Asunto(s)
Lentes de Contacto , Queratocono , Lentes de Contacto/efectos adversos , Córnea , Topografía de la Córnea , Dilatación Patológica , Humanos , Queratocono/terapia , EscleróticaRESUMEN
This article evaluates the effects of Muller's muscle-conjunctival resection (MMCR) on ocular surface scores and dry eye symptoms. Forty-six patients were enrolled in the study. Eighteen underwent bilateral upper eyelid skin excision with MMCR and 28 underwent bilateral upper eyelid skin-only excision (control group). The Salisbury Eye Evaluation Questionnaire and an ocular surface evaluation protocol consisting of Schirmer's test, tear break-up time (TBUT), fluorescein and rose bengal corneal staining were performed during the pre-operative consultation and on postoperative days 7, 30, and 90. Improvement in symptoms questionnaire scores from baseline was observed on postoperative day 90 in the blepharoplasty plus MMCR group. There was no change in questionnaire scores in patients who underwent blepharoplasty alone. No between-group difference in Schirmer's test, TBUT, or fluorescein and rose bengal staining was found at any time point. In the blepharoplasty-only (control group), the fluorescein staining score was reduced on postoperative day 30 as compared to baseline, but not on day 90. In this sample, addition of MMCR to upper eyelid blepharoplasty did not worsen ocular surface scores or dry eye symptoms.
Asunto(s)
Blefaroplastia , Blefaroptosis/cirugía , Conjuntiva/cirugía , Síndromes de Ojo Seco/fisiopatología , Párpados/cirugía , Músculos Oculomotores/cirugía , Anciano , Blefaroptosis/fisiopatología , Conjuntiva/fisiopatología , Párpados/fisiopatología , Femenino , Fluorofotometría , Humanos , Masculino , Persona de Mediana Edad , Músculos Oculomotores/fisiopatología , Estudios Prospectivos , Encuestas y Cuestionarios , Lágrimas/fisiologíaRESUMEN
The kallikrein inhibitor found in Bauhinia bauhinioides seeds (BbKI) differs from classical Kunitz plant inhibitors in the lack of disulfide bridges in its structure [Biochim. Biophys. Acta 1477 (2000) 64-74]. In this study, we examined whether structural properties may be involved in inhibitory specificity and, if so, whether those properties might be useful tools in designing compounds that interfere with enzyme activity. Peptides structurally related to the BbKI (RPGLPVRFESPLRINIIKE-NH(2)) reactive site were synthesized by solid-phase method and assayed for serine proteinase activity. The peptides RPGLPVRFESPLRINIIKE-NH(2), RPGLPVRFESPL-NH(2), and GLPVRFES-NH(2) were efficient tissue kallikrein inhibitors, with I(50) values of 0.54 microM, 0.87 microM, and 0.5mM, respectively. The lasting inhibitory effect was observed in incubation periods of up to 120 min. None of the studied peptides interfere with the activity of thrombin, factor Xa or trypsin, although the native protein BbKI is a potent trypsin inhibitor.
Asunto(s)
Factor Xa/química , Proteínas de Plantas/química , Proteínas de Plantas/clasificación , Serina Endopeptidasas/química , Serina Endopeptidasas/efectos de los fármacos , Trombina/química , Tripsina/química , Secuencia de Aminoácidos , Activación Enzimática , Inhibidores Enzimáticos/química , Datos de Secuencia Molecular , Péptidos/química , Relación Estructura-Actividad , Especificidad por SustratoRESUMEN
Este artigo propõe revisar uma nova classe de drogas utilizadas no tratamento do Diabete Melito Tipo 2, já presente nos algoritmos de tratamento desta doença.
Asunto(s)
Peso Corporal , /tratamiento farmacológico , Hipoglucemia , IncretinasRESUMEN
Neste artigo, os autores fazem uma revisão bibliográfica sobre a conjuntivite alérgica e seus subtipos, abordando suas manifestações clinicas, fisiopatologia, diagnóstico e manejo específicos.